Modulation of Gal-3 secretion by exosomes is an interesting concept and potential therapeutic approach because our recent review shows that naturally occurring or engineered exosomes derived from stem cells, or potentially other cell types, provide therapeutic effects in AD [35, 36]. The gene discussed is LGALS3; the disease is Alzheimer disease.